Home
Resources
Product Analysis
Acknowledgements
About
Home
References
Countries
Countries
USA
Products 11 to 20 of 188
Modify Display Properties
Biotech components
Business models
Country of production
Country of distribution
Intended consumer
Date added
Date last modified
Known funding amount
Funding types
Industry
Market status
Organization
Organization type(s)
Product categories
Production process
Source
Trading symbol
Value chain stage
Sort: Title (A-Z)
Date added (oldest-newest)
Date added (newest-oldest)
Date modified (oldest-newest)
Date modified (newest-oldest)
Title (A-Z)
Title (Z-A)
Organization (A-Z)
Organization (Z-A)
Archetype: Sequence Genome Anotation Software
by
SGI-DNA
+
Synthetic Genomics
Biotech components:
N/A
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Research
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/09/28 16:59 (6 years ago)
Known funding amount:
40,000,000 USD
Funding types:
Venture Capital
Industry:
Science
Market status:
On the market
Organization type(s):
Private Company
Product categories:
Design
Production process:
Closed Production
Source:
NASEM Database
Trading symbol:
N/A
Value chain stage:
Platform
Arctic Apple
by
Okanagan Specialty Fruits
+
Intrexon
Biotech components:
Plant
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
+
Canada
Intended consumer:
Consumer
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/10/02 15:47 (6 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Food
Production process:
Open Release
Source:
NASEM Database
Trading symbol:
XON
(NYSE)
Value chain stage:
Finished Product
Artemisinic Acid
by
Amyris
Biotech components:
Probiotic
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
+
Africa
+
France
Intended consumer:
Commercial
+
Government
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
471,900,000 USD
Funding types:
Shareholder Investment
Industry:
Health
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Chemical
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
AMRS
(NASDAQ)
Value chain stage:
Input
Attenuated Virus Cultures for Vaccine Production
by
J. Craig Venter
Biotech components:
Virus
Business models:
B2B
Country of production:
USA
Country of distribution:
N/A
Intended consumer:
Commercial
+
Government
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
27,400,000 USD
Funding types:
Research Institution
Industry:
Health
Market status:
Under Development
Organization type(s):
University
+
Research Institution
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Input
Bacteria Strains for Companies to Use in Fermentors
by
Ginkgo Bioworks
Biotech components:
Enzyme
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
6,438,793 USD
Funding types:
Government
Industry:
Science
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Research
Production process:
Closed Production
Source:
NASEM Database
Trading symbol:
N/A
Value chain stage:
Platform
Bacterial Live Wires
by
Berkeley Lab
Biotech components:
Bacteria
Business models:
B2B
Country of production:
USA
Country of distribution:
N/A
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
N/A
Funding types:
Research Institution
Industry:
Science
Market status:
Early Stage Concept
Organization type(s):
University
+
Research Institution
Product categories:
Research
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Input
Bacteriophage Treatment
by
MIT
Biotech components:
Virus
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
+
Government
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
N/A
Funding types:
Private Funding
Industry:
Health
Market status:
Under Development
Organization type(s):
University
+
Research Institution
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Finished Product
Beef
by
Memphis Meats
Biotech components:
Animal
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Consumer
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/10/02 11:48 (6 years ago)
Known funding amount:
20,100,000 USD
Funding types:
Venture Capital
Industry:
Food & Agriculture
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Food
Production process:
Closed Production
Source:
NASEM Database
Trading symbol:
N/A
Value chain stage:
Finished Product
Bio-based 1,3 Butedine
by
Invista
Biotech components:
Molecule
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Chemical
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Input
Bio-based 1,4 Butanediol
by
BioAmber, Inc.
Biotech components:
Plant
Business models:
B2B
Country of production:
USA
Country of distribution:
Canada
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/11/08 14:28 (6 years ago)
Known funding amount:
3,000,000 CAN
Funding types:
Debtor-in-possession financing
+
Shareholder Investment
Industry:
Industrial
Market status:
More information needed
+
No longer on the market
Organization type(s):
Public Company
Product categories:
Chemical
Production process:
Closed Production
Source:
NASEM Database
Trading symbol:
BIOA
(NYSE)
Value chain stage:
Input
1
2
3
4
5
6
7
8
9
10
…
19
Login
or
register
to add and edit products
Future
Bioengineered
Products
Home
Resources
Product Analysis
Acknowledgements
About
